ArticleNature communications2018

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target.

Olli Dufva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.